I just watched AKRO double in premarket after reporting significant results on cirrhosis treatment. It's shown strong potential, and I believe it's se...
Read
More
I just watched AKRO double in premarket after reporting significant results on cirrhosis treatment. It's shown strong potential, and I believe it's set to maintain its momentum today, making it a prime candidate for a day trade in the short term.